Riaz Alvi Selected Research

gastrointestinal tract acid-446

1/2013

Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riaz Alvi Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 07/2008
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2009
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 07/2008

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2022 - 07/2018
1	antineoplaston A10 (A 10)IBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	ElementsIBA 01/2016
1	Histones (Histone)IBA 01/2016
1	MethyltransferasesIBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	sodium bisulfite FDA Link 01/2016
1	gastrointestinal tract acid-446IBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013

Therapy/Procedure

5	Therapeutics 01/2021 - 07/2008
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2009
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Oral Administration 07/2018
1	Adjuvant Chemotherapy 09/2014
1	Aftercare (After-Treatment) 07/2008
1	Radiotherapy 07/2008
1	Brachytherapy 07/2008